Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
Saved in:
| Title: | Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. |
|---|---|
| Authors: | Hawley JE; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York.; now with Division of Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle., Sun T; Vanderbilt University Medical Center, Nashville, Tennessee., Chism DD; Thompson Cancer Survival Center, Knoxville, Tennessee., Duma N; University of Wisconsin Carbone Cancer Center, Madison., Fu JC; Tufts Medical Center Cancer Center, Boston and Stoneham, Massachusetts., Gatson NTN; Geisinger Health System, Danville, Pennsylvania.; Banner MD Anderson Cancer Center, Gilbert, Arizona., Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee., Nguyen RH; University of Illinois Hospital & Health Sciences System, Chicago., Reid SA; Vanderbilt University Medical Center, Nashville, Tennessee., Serrano OK; Hartford HealthCare Cancer Institute, Hartford, Connecticut., Singh SRK; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan., Venepalli NK; University of North Carolina, Lineberger Cancer Center, Chapel Hill., Bakouny Z; Dana-Farber Cancer Institute, Boston, Massachusetts., Bashir B; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia., Caimi PF; Case Comprehensive Cancer Center at Case Western Reserve University/University Hospitals, Cleveland, Ohio., Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts., Dawsey SJ; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor., Flora DB; St Elizabeth Healthcare, Edgewood, Kentucky., Friese CR; University of Michigan Rogel Cancer Center, Ann Arbor., Glover MJ; Stanford Cancer Institute at Stanford University, Palo Alto, California., Gonzalez CJ; University of Michigan Rogel Cancer Center, Ann Arbor., Goyal S; George Washington University, Washington, DC., Halfdanarson TR; Mayo Clinic, Rochester, Minnesota., Hershman DL; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York., Khan H; Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Labaki C; Dana-Farber Cancer Institute, Boston, Massachusetts., Lewis MA; Intermountain Healthcare, Salt Lake City, Utah., McKay RR; University of California, San Diego., Messing I; George Washington University, Washington, DC., Pennell NA; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Puc M; Virtua Health, Marlton, New Jersey., Ravindranathan D; Winship Cancer Institute of Emory University, Atlanta, Georgia., Rhodes TD; Intermountain Healthcare, Salt Lake City, Utah., Rivera AV; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania., Roller J; University of Kansas Medical Center, Kansas City., Schwartz GK; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York., Shah SA; Stanford Cancer Institute at Stanford University, Palo Alto, California., Shaya JA; University of California, San Diego., Streckfuss M; Advocate Aurora Health, Milwaukee, Wisconsin., Thompson MA; Advocate Aurora Health, Milwaukee, Wisconsin., Wulff-Burchfield EM; University of Kansas Medical Center, Kansas City., Xie Z; Mayo Clinic, Rochester, Minnesota., Yu PP; Hartford HealthCare Cancer Institute, Hartford, Connecticut., Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee., Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas., French B; Vanderbilt University Medical Center, Nashville, Tennessee., Hwang C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan. |
| Corporate Authors: | COVID-19 and Cancer Consortium (CCC19) |
| Source: | JAMA network open [JAMA Netw Open] 2022 Jan 04; Vol. 5 (1), pp. e2142046. Date of Electronic Publication: 2022 Jan 04. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
